ARCHIVES

House Members Urge FDA to Review Fast Track Policies

This article is from The Cancer Letter archive.

Vol. 28 No. 27 | July 5, 2002

Download PDF Visit The Full Archive

Related Articles

Small But Valued NIH Grant Program Cut In FY92 Budget

April 12, 1991

Phase III Tecemotide Trial Fails OS Endpoint; Second Trial Planned After Subgroup Analysis

December 27, 2013

FDA News: Zydelig approved in three B-cell blood cancers

August 1, 2014

Cancer Genome Atlas Reveals Similarities Between Certain Breast and Ovarian Cancers

September 28, 2012

NCAB Decides To End IGs, Review total Research Support, And Consider P01 Limitation

June 12, 1992

The White House: Justice Department May Sue Tobacco Firms, Clinton Says

January 22, 1999